INTRODUCTION
SESSION I: BASIC KNOWLEDGE FOR CV DEVICES DEVELOPMENT
Biostatistics
10 Topics | 10 Quizzes
SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
SESSION IV: TRANSLATIONAL PATHWAY FOR CORONARY STENT
SESSION V: TRANSLATIONAL PATHWAY FOR CATHETER ABLATION
SESSION VI: TRANSLATIONAL PATHWAY FOR VENTRICULAR ASSIST DEVICES
SESSION VII: TRANSLATIONAL PATHWAY FOR INTERVENTIONAL DEVICES FOR HEART FAILURE
SESSION VIII: TRANSLATIONAL PATHWAY FOR LEFT ATRIAL APPENDAGE CLOSURE DEVICES
Supplemental Session

The TAVR Development from Concept to First in Man

Alain Cribier, MD

Professor of Medicine and Director of Cardiology at the

University of Rouen, Charles Nicolle Hospital, France

Learning Objectives

  • Recognize the challenges to design iteration
  • Understand the tailored trial design
  • Learn the regulatory pathway for approval for device iteration
  • Learn the regulatory pathway for approval for indication expansion
  • Learn the use of real world data
Hide picture